110 related articles for article (PubMed ID: 4015743)
21. Allopurinol and oxypurinol are hydroxyl radical scavengers.
Moorhouse PC; Grootveld M; Halliwell B; Quinlan JG; Gutteridge JM
FEBS Lett; 1987 Mar; 213(1):23-8. PubMed ID: 3030809
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
23. Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
Day RO; Miners J; Birkett DJ; Graham GG; Whitehead A
Br J Clin Pharmacol; 1988 Oct; 26(4):429-34. PubMed ID: 3190993
[TBL] [Abstract][Full Text] [Related]
24. Sustained reductions in oxipurinol renal clearance during a restricted diet.
Park GD; Berlinger WG; Spector R; Kitt TM; Tsalikian E
Clin Pharmacol Ther; 1987 Jun; 41(6):616-21. PubMed ID: 3581647
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a thiazide-allopurinol drug interaction.
Hande KR
Am J Med Sci; 1986 Oct; 292(4):213-6. PubMed ID: 3752167
[TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic studies on plasma elimination half-life of oxipurinol (author's transl)].
Lach HJ; Bader B; Schnitker J; Harries EH
Arzneimittelforschung; 1982; 32(1):76-9. PubMed ID: 7199345
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Mills PC; Dunnett M; Smith NC
J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
[TBL] [Abstract][Full Text] [Related]
29. Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
Walter-Sack I; de Vries JX; Kreiner C; Ittensohn A; Stenzhorn G; Voss A; Weber E
Clin Investig; 1993 Mar; 71(3):240-6. PubMed ID: 8481628
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
Nelson DJ; Bugge CJ; Elion GB; Berens RL; Marr JJ
J Biol Chem; 1979 May; 254(10):3959-64. PubMed ID: 438170
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
Day RO; Graham GG; Hicks M; McLachlan AJ; Stocker SL; Williams KM
Clin Pharmacokinet; 2007; 46(8):623-44. PubMed ID: 17655371
[TBL] [Abstract][Full Text] [Related]
32. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
[TBL] [Abstract][Full Text] [Related]
33. [The bioequivalence of a new allopurinol tablet formulation in comparison to a reference formulation].
Metzner JE; Buchberger D; Läuter J; Pech R
Arzneimittelforschung; 1997 Nov; 47(11):1236-41. PubMed ID: 9463301
[TBL] [Abstract][Full Text] [Related]
34. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
36. Oxipurinol therapy in allopurinol-allergic patients.
Earll JM; Saavedra M
Am Fam Physician; 1983 Nov; 28(5):147-8. PubMed ID: 6637745
[No Abstract] [Full Text] [Related]
37. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
39. [Saliva and serum concentrations of oxipurinol after a single oral dose of allopurinol].
Mühlenbruch B; Arndt ML
Arch Pharm (Weinheim); 1982 Sep; 315(9):811-3. PubMed ID: 7138246
[No Abstract] [Full Text] [Related]
40. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
